Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
about
Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolutionClinical implications of the molecular genetics of chronic lymphocytic leukemiaThe biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemiaClonal evolution in hematological malignancies and therapeutic implicationsIntegrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemiaThe role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we goAcquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants.Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.Characteristics of chronic lymphocytic leukemia in SenegalQuantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia.Monoallelic and biallelic deletions of 13q14 in a group of CLL/SLL patients investigated by CGH Haematological Cancer and SNP array (8x60K).Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive diseaseClonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemiaGenetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic LeukemiaChronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.Clinical application of targeted and genome-wide technologies: can we predict treatment responses in chronic lymphocytic leukemia?Genome-wide arrays in routine diagnostics of hematological malignancies.Molecular diagnosis of leukemia.Exploring the genetic landscape in chronic lymphocytic leukemia using high-resolution technologies.Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.Uncovering the DNA methylome in chronic lymphocytic leukemia.Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Clonal evolution in chronic lymphocytic leukemia: impact of subclonality on disease progression.Inhibition of MicroRNA miR-222 with LNA Inhibitor Can Reduce Cell Proliferation in B Chronic Lymphoblastic Leukemia.Clinical Implications of Novel Genomic Discoveries in Chronic Lymphocytic Leukemia.SNP Array in Hematopoietic Neoplasms: A Review.Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference.Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.Activation of the NOTCH1 pathway in chronic lymphocytic leukemia.Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis.Structural alterations in chronic lymphocytic leukaemia. Cytogenetic and FISH analysis.2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation.Genomic imbalance defines three prognostic groups for risk stratification of patients with chronic lymphocytic leukemia.Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance.
P2860
Q26823586-8BE37E72-9763-4395-9FBF-15C1FDA14168Q26830955-D5B91FE5-3518-4460-BB76-147A7DAC870EQ27024411-0E85CDCA-0129-4337-9E67-7E14651B7D1DQ27027655-B291AFB7-ABF3-470D-9018-A77934549920Q28394721-074591CF-EF25-411C-B526-08213CAAB212Q33409459-C1C735ED-5D63-4340-A130-CD7A816B0AC3Q33567169-DC01BC5A-AC36-4AE3-9A11-191D0DC5C7ECQ33744997-9DB7FD23-330B-499A-B41A-2046AAB72C2CQ33818637-B4CE41EF-E24E-4EA6-8190-B8892C6C41BDQ35650512-4E424EA9-075A-4BAD-B761-A614904CCBA6Q35860550-875FEC23-AFEE-48F0-9ACA-96C84FF07128Q35984259-CF011060-576D-491F-890C-E76DCFA3B679Q35997917-CE5981D9-C54A-4D5E-A623-F99EABA87048Q36421804-45280118-082A-4B6F-98DF-9EEF36F647DFQ36433299-33D9EE20-834E-48A9-9A1B-FCE6E98E5724Q36799831-2E5C9CE8-53EB-42B7-8865-4133F69638D7Q36884141-670BA472-5E97-4481-85A1-1EC6A2DC5BDEQ36906625-56CBDFAB-B70D-4EF3-BAC9-CD6D0BC816D7Q37225819-1B31D128-662A-4708-8E18-9B7BAF6D02BAQ37615541-3FE871A2-D6B4-4301-96ED-C54241F89C8AQ37618663-B8BEFB87-CD02-4340-8ACF-064827119464Q38001406-413D990B-5724-4E4A-AE53-F83427B80B2FQ38018998-D4AF1E36-FD10-4DA8-9A00-1120DFEFE59CQ38061177-DF751FEC-C017-4097-8028-A05C44068C32Q38071077-EC5B4A95-4419-42B1-A04A-2F052C096994Q38074267-70694DB3-A77F-4B6B-9BBD-08BAB6171129Q38088354-1470B897-844C-4A50-9FD6-BCEBA457E9E0Q38262761-9BD6D6AB-4C56-4DE7-9139-9CCD46E70900Q38616907-D69EE2A6-54BE-4F1C-91C5-578429B75964Q38744632-6295C705-24CC-45FA-AE6D-1BEB89D699E0Q38947537-51DE28E0-EA3F-41F5-8B46-8606FA6FD63BQ42399823-195C12AB-522F-4F9E-81B0-061003DF6568Q42537560-2A083CA9-E3ED-45A4-8C10-2978CC335132Q42615857-E45ABDA5-D6E7-47B2-B694-5BEF637E19DCQ42789949-136A07C3-7D10-4DE1-9A30-59968EAF1939Q43971337-D8736ABD-D326-440D-B3B4-E4FAE923704BQ44438293-A1ADA519-740D-4246-9D61-A82333D50752Q44882002-A14777B1-BCF8-4719-965A-F70D07AAB8F5Q45988365-29B611CD-0B8D-4379-BC95-B1FEFB3BF14BQ47916143-ADA59C75-8693-43AF-BE02-F4C89742F2E3
P2860
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Array-based genomic screening ...... chronic lymphocytic leukemia.
@ast
Array-based genomic screening ...... chronic lymphocytic leukemia.
@en
type
label
Array-based genomic screening ...... chronic lymphocytic leukemia.
@ast
Array-based genomic screening ...... chronic lymphocytic leukemia.
@en
prefLabel
Array-based genomic screening ...... chronic lymphocytic leukemia.
@ast
Array-based genomic screening ...... chronic lymphocytic leukemia.
@en
P2093
P2860
P50
P1433
P1476
Array-based genomic screening ...... chronic lymphocytic leukemia.
@en
P2093
Anne Mette Buhl
Christian Geisler
Gunnar Juliusson
Hanna Göransson
Jeanette Lundin
Jesper Jurlander
Karin Karlsson
Larry Mansouri
Markus Rasmussen
Mattias Jansson
P2860
P304
P356
10.3324/HAEMATOL.2010.039768
P577
2011-05-05T00:00:00Z